Skip to Main Content

Paper Details

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8<sup>+</sup> T cell fate.
Nat Commun
49
2019
Author NameAffiliation
Veena KapoorCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Veena KapoorCenter for Cancer Research, National Cancer Institute, National Institutes of Health
William G TelfordCenter for Cancer Research, National Cancer Institute, National Institutes of Health
William G TelfordCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Vittorio SartorelliNational Institute of Arthritis, National Institutes of Health
  • 1 - 5

Datasets

Release 1.2